Logo image of ESRT

EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ESRT - US2921041065 - REIT

6.525 USD
-0.02 (-0.38%)
Last: 12/23/2025, 12:26:48 PM
Fundamental Rating

4

ESRT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 128 industry peers in the Diversified REITs industry. ESRT has only an average score on both its financial health and profitability. ESRT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ESRT had positive earnings in the past year.
ESRT had a positive operating cash flow in the past year.
In multiple years ESRT reported negative net income over the last 5 years.
In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

ESRT's Return On Assets of 0.85% is in line compared to the rest of the industry. ESRT outperforms 51.56% of its industry peers.
Looking at the Return On Equity, with a value of 3.25%, ESRT is in line with its industry, outperforming 56.25% of the companies in the same industry.
The Return On Invested Capital of ESRT (2.87%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.05%.
The 3 year average ROIC (2.75%) for ESRT is below the current ROIC(2.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

ESRT's Profit Margin of 4.55% is in line compared to the rest of the industry. ESRT outperforms 49.22% of its industry peers.
ESRT's Profit Margin has declined in the last couple of years.
The Operating Margin of ESRT (18.68%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ESRT has remained more or less at the same level.
The Gross Margin of ESRT (54.04%) is worse than 75.00% of its industry peers.
ESRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ESRT is destroying value.
The number of shares outstanding for ESRT has been increased compared to 1 year ago.
Compared to 5 years ago, ESRT has less shares outstanding
The debt/assets ratio for ESRT is higher compared to a year ago.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
ESRT has a Altman-Z score (0.58) which is in line with its industry peers.
A Debt/Equity ratio of 1.92 is on the high side and indicates that ESRT has dependencies on debt financing.
ESRT has a worse Debt to Equity ratio (1.92) than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACC0.48
WACC6%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.59 indicates that ESRT has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.59, ESRT belongs to the best of the industry, outperforming 89.06% of the companies in the same industry.
ESRT has a Quick Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
ESRT's Quick ratio of 2.59 is amongst the best of the industry. ESRT outperforms 89.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
ESRT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.83% yearly.
The Revenue has been growing slightly by 0.45% in the past year.
ESRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.98% yearly.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%

3.2 Future

ESRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -37.27% yearly.
The Revenue is expected to grow by 1.75% on average over the next years.
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

ESRT is valuated cheaply with a Price/Earnings ratio of 7.41.
Compared to the rest of the industry, the Price/Earnings ratio of ESRT indicates a rather cheap valuation: ESRT is cheaper than 95.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.61, ESRT is valued rather cheaply.
The Price/Forward Earnings ratio is 106.62, which means the current valuation is very expensive for ESRT.
ESRT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of ESRT to the average of the S&P500 Index (24.01), we can say ESRT is valued expensively.
Industry RankSector Rank
PE 7.41
Fwd PE 106.62
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

ESRT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ESRT is cheaper than 89.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.07
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as ESRT's earnings are expected to decrease with -56.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%

3

5. Dividend

5.1 Amount

ESRT has a Yearly Dividend Yield of 2.08%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 6.33, ESRT's dividend is way lower than its industry peers. On top of this 86.72% of the companies listed in the same industry pay a better dividend than ESRT!
Compared to an average S&P500 Dividend Yield of 1.87, ESRT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of ESRT decreases each year by -17.38%.
ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

ESRT pays out 79.65% of its income as dividend. This is not a sustainable payout ratio.
ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (12/23/2025, 12:26:48 PM)

6.525

-0.02 (-0.38%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners100.65%
Inst Owner Change3.69%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.11B
Revenue(TTM)766.65M
Net Income(TTM)34.89M
Analysts75
Price Target8.73 (33.79%)
Short Float %3.47%
Short Ratio3.63
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-Date12-15 2025-12-15 (0.035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.39%
PT rev (3m)-3.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 7.41
Fwd PE 106.62
P/S 1.45
P/FCF N/A
P/OCF 4.19
P/B 1.03
P/tB 4.05
EV/EBITDA 9.07
EPS(TTM)0.88
EY13.49%
EPS(NY)0.06
Fwd EY0.94%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY23.88%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.18
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.58
F-Score6
WACC6%
ROIC/WACC0.48
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%
EBIT growth 1Y-8.53%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.48%
EBIT Next 3Y34.61%
EBIT Next 5Y20.13%
FCF growth 1Y96.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.72%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


How profitable is EMPIRE STATE REALTY TRUST-A (ESRT) stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


How financially healthy is EMPIRE STATE REALTY TRUST-A?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.


What is the expected EPS growth for EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The Earnings per Share (EPS) of EMPIRE STATE REALTY TRUST-A (ESRT) is expected to decline by -88.67% in the next year.